Eli Lilly appears to be fattening its stockpiles of GLP-1s as the threat of tariffs on pharmaceuticals looms. sherwood.news/world/eli-li...

In the first quarter of 2025, $68.7 billion in pharmaceutical products were imported compared to $48.7 billion in the same quarter period last year.

Virtually every healthcare company that has filed a proxy statement so far this year reported increased spending on protecting their executives in 2024.

Sweetgreen is down after a big earnings miss and a grim outlook for 2025. The corporate lunchtime favorite hasn't turned a profit in 10 years.

sherwood.news/markets/swee...

Eli Lilly and Novo Nordisk's GLP-1 drugs brought in over $40 billion in sales in 2024. sherwood.news/business/eli...

The economies of the United States and Mexico are more intertwined than they've ever been. So are their drinking habits.

sherwood.news/world/americ...